Exscientia is pleased to announce its first collaboration with a Japanese pharmaceutical company, Sumitomo Dainippon Pharma Co., Ltd. This agreement builds on three earlier agreements with US based pharmaceutical companies. Financial terms were not disclosed.
March 1, 2014
Bispecific drug discovery agreement with Sumitomo Dainippon Pharma Co., Ltd
Liked the article? Let’s share it!